{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:20:08Z","timestamp":1778869208202,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jaad.2025.05.1376","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T11:02:27Z","timestamp":1746874947000},"page":"671-677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy, safety, and recurrence in seborrheic dermatitis: A dose-dependent analysis of oral isotretinoin (10 mg vs 20 mg)"],"prefix":"10.1016","volume":"93","author":[{"given":"Abdullah","family":"Demirbas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esin","family":"Diremsizoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Esen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gozde Ulutas","family":"Demirbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jaad.2025.05.1376_bib1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13555-025-01351-z","article-title":"Child and adult seborrheic dermatitis: a narrative review of the current treatment landscape","volume":"15","author":"Vidal","year":"2025","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"8","key":"10.1016\/j.jaad.2025.05.1376_bib2","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/jamadermatol.2024.1987","article-title":"The global prevalence of seborrheic dermatitis: a systematic review and meta-analysis","volume":"160","author":"Polaskey","year":"2024","journal-title":"JAMA Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2025.05.1376_bib3","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/ijd.17324","article-title":"Adult and infantile seborrheic dermatitis: update on current state of evidence and potential research frontiers","volume":"63","author":"Rau","year":"2024","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.05.1376_bib4","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.3390\/ijms26062650","article-title":"Seborrheic dermatitis: exploring the complex interplay with Malassezia","volume":"26","author":"Piacentini","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"17","key":"10.1016\/j.jaad.2025.05.1376_bib5","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3661","article-title":"Risk factors for seborrhoeic dermatitis flares: case-control and case-crossover study","volume":"100","author":"Lancar","year":"2020","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2025.05.1376_bib6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12955-020-01558-y","article-title":"Clinical characteristics and quality of life in seborrheic dermatitis patients: a cross-sectional study in China","volume":"18","author":"Xuan","year":"2020","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"10.1016\/j.jaad.2025.05.1376_bib7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3390\/cosmetics11060208","article-title":"Seborrheic dermatitis: from microbiome and skin barrier involvement to emerging approaches in dermocosmetic treatment","volume":"11","author":"Galizia","year":"2024","journal-title":"Cosmetics"},{"issue":"1","key":"10.1016\/j.jaad.2025.05.1376_bib8","article-title":"The psychosocial impact of chronic facial dermatoses in adults","volume":"13","author":"Ozcan","year":"2023","journal-title":"Dermatol Pract Concept"},{"issue":"4","key":"10.1016\/j.jaad.2025.05.1376_bib9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000506627","article-title":"Anxiety, depression, and suicidal ideation amongst patients with facial dermatoses (acne, rosacea, perioral dermatitis, and folliculitis) in Lithuania","volume":"236","author":"Lukaviciute","year":"2020","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.jaad.2025.05.1376_bib10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/09546634.2018.1473554","article-title":"Treatment of seborrheic dermatitis: a comprehensive review","volume":"30","author":"Borda","year":"2019","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"10.1016\/j.jaad.2025.05.1376_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/19381980.2017.1361573","article-title":"Cutaneous fungal microbiome: Malassezia yeasts in seborrheic dermatitis scalp in a randomized, comparative and therapeutic trial","volume":"9","author":"Kamamoto","year":"2017","journal-title":"Dermatoendocrinol"},{"issue":"9","key":"10.1016\/j.jaad.2025.05.1376_bib12","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/jid.2012.111","article-title":"Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients","volume":"132","author":"Dispenza","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.05.1376_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5114\/pdia.2014.40655","article-title":"Pro-inflammatory cytokines in patients with various kinds of acne treated with isotretinoin","volume":"31","author":"Bergler-Czop","year":"2014","journal-title":"Postepy Dermatol Alergol"},{"issue":"4","key":"10.1016\/j.jaad.2025.05.1376_bib14","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/jid.2008.338","article-title":"Isotretinoin temporally regulates distinct sets of genes in patient skin","volume":"129","author":"Nelson","year":"2009","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.05.1376_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/ijd.13408","article-title":"Low-dose oral isotretinoin for moderate to severe seborrhea and seborrheic dermatitis: a randomized comparative trial","volume":"56","author":"de Souza Le\u00e3o Kamamoto","year":"2017","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.05.1376_bib16","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/ijd.16582","article-title":"Efficacy and safety of oral isotretinoin in the treatment of moderate to severe seborrheic dermatitis: a retrospective study","volume":"62","author":"Yanfei","year":"2023","journal-title":"Int J Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2025.05.1376_bib17","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1046\/j.1365-2303.2003.00108.x-i1","article-title":"Very low dose isotretinoin is effective in controlling seborrhea","volume":"1","author":"Geissler","year":"2003","journal-title":"J Dtsch Dermatol Ges"},{"issue":"2","key":"10.1016\/j.jaad.2025.05.1376_bib18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/1203475416676806","article-title":"Low-dose isotretinoin for seborrhoeic dermatitis","volume":"21","author":"Rademaker","year":"2017","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2025.05.1376_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.733526","article-title":"Advantages of tailored isotretinoin treatment in moderate to severe acne: real-life data","volume":"12","author":"Skroza","year":"2021","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.jaad.2025.05.1376_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14392","article-title":"Efficacy and safety of systemic isotretinoin treatment for moderate to severe acne (insights from the real-life clinical setting)","volume":"33","author":"Tolino","year":"2020","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.jaad.2025.05.1376_bib21","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/jvc2.154","article-title":"A systematic review of isotretinoin dosing in acne vulgaris","volume":"2","author":"Daly","year":"2023","journal-title":"JEADV Clin Pract"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225021140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225021140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:06:53Z","timestamp":1755648413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225021140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0190962225021140"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.05.1376","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, safety, and recurrence in seborrheic dermatitis: A dose-dependent analysis of oral isotretinoin (10 mg vs 20 mg)","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.05.1376","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}